Overexpression of the programmed death-1 (PD-1) ligand 1 (PD-L1) that regulates tumor microenvironment during EMT has been attributed to decreased DNMT1 levels in lung cancer cells which lead to demethylation of the PD-L1 promoter, changing its expression [82]. The gene discussed is CD274; the disease is lung cancer.